Literature DB >> 11358832

Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma.

M J Roth1, N Hu, M R Emmert-Buck, Q H Wang, S M Dawsey, G Li, W J Guo, Y Z Zhang, P R Taylor.   

Abstract

Esophageal squamous cell carcinoma is a common fatal cancer, and Shanxi province, a region in north-central China, has some of the highest esophageal cancer rates in the world. Chromosomal regions with frequent allelic loss may point to major susceptibility genes that will assist us in understanding the molecular events involved in esophageal carcinogenesis and may serve as the basis for the development of markers for genetic susceptibility and screening for early detection of this cancer. This study was designed to identify events in the molecular progression of precursor and invasive lesions of squamous esophageal cancer. Twelve marker loci identified during our previous studies as having some of the highest rates of loss of heterozygosity (LOH) in invasive esophageal cancer were evaluated in laser-microdissected DNA obtained from low- and high-grade dysplastic lesions and invasive tumor foci from 10 fully embedded esophageal resection specimens. Each resection specimen contained a spectrum of disease, from epithelium that appeared histologically normal to invasive cancer, including a single dominant tumor surrounded by a region of precursor lesions (low- and high-grade dysplasia) and occasional "remote," nonadjacent precancerous foci. Using the 12 polymorphic markers, LOH was found in all of the three stages of disease. The frequency of LOH for all of the markers together increased with increasing disease severity. Among the informative low-grade dysplasia samples, LOH was detected with markers D3S1766 (3p), D4S2632 (4p), D9S910 (9q), and D13S1493 (13q), suggesting that LOH at these loci may be associated with early stages of tumor initiation and/or progression. LOH was detected among the informative high-grade (but not low-grade) dysplasia samples for the other eight markers tested, suggesting that LOH at these loci may occur later in the neoplastic process. In addition to the association between disease progression and these genetic changes, considerable genetic heterogeneity was found in each fully embedded resection specimen both between and within geographically separate neoplastic lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358832

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Overexpression of ETS2 in human esophageal squamous cell carcinoma.

Authors:  Xin Li; Jia-Yun Lu; Li-Qun Zhao; Xiu-Qin Wang; Gui-Lin Liu; Zhong Liu; Chuan-Nong Zhou; Min Wu; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

2.  Loss of heterozygosity in multistage carcinogenesis of esophageal carcinoma at high-incidence area in Henan Province, China.

Authors:  Ji-Ye An; Zong-Min Fan; Shan-Shan Gao; Ze-Hao Zhuang; Yan-Ru Qin; Ji-Lin Li; Xin He; George-Sai-Wah Tsao; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

3.  Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma.

Authors:  Philip R Taylor; Christian C Abnet; Sanford M Dawsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

4.  Down-regulation of gut-enriched Kruppel-like factor expression in esophageal cancer.

Authors:  Nan Wang; Zhi-Hua Liu; Fang Ding; Xiu-Qin Wang; Chuan-Nong Zhou; Min Wu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma.

Authors:  Bo Li; Bing Wang; Li-Juan Niu; Lei Jiang; Chang-Chun Qiu
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 6.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

7.  Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China.

Authors:  Zhang Guohong; Su Min; Wang Duenmei; Hu Songnian; Liu Min; Li Jinsong; Lin Hongbin; Zhang Feng; Tian Dongping; Yang Heling; Liu Zhicai; Lian Shiyong; Guo Quansheng; Li Xiaoyun; Gao Yuxia
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

8.  Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  Jian-Chun Cai; Di Liu; Kai-Hua Liu; Hai-Ping Zhang; Shan Zhong; Ning-Sao Xia
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

9.  Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma.

Authors:  Shun He; Guang-Ming Guo; Fu-Xing Liu; Xiao-Ping Huang; Xin Xu; Yan Cai; Ya-Ling Han; Qi-Min Zhan; Min Wu; Jin-Tang Dong; Gui-Qi Wang; Ming-Rong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-14       Impact factor: 4.553

10.  Attenuation of krüppel-like factor 4 facilitates carcinogenesis by inducing g1/s phase arrest in clear cell renal cell carcinoma.

Authors:  Erlin Song; Xin Ma; Hongzhao Li; Peng Zhang; Dong Ni; Weihao Chen; Yu Gao; Yang Fan; Haigang Pang; Taoping Shi; Qiang Ding; Baojun Wang; Yu Zhang; Xu Zhang
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.